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Abstract
Abstract
Toxicovigilance is the active process of identifying and evaluating the toxic risks existing in
a community, and evaluating the measures taken to reduce or eliminate them.
Objective
Through a validated toxicovigilance program (SAT-HULP) we examined the characteristics
of acute poisoning cases (APC) attended in the Emergency Department (ED) of La Paz
Hospital (Madrid, Spain) and assessed their economic impact on the health system.
Material and Methods
The active poisoning surveillance system performs a daily search for cases in the hospital´s
computerized case records. Found cases are entered into a database for recording of type
of poisoning episode, reasons for exposure, causative agent, signs and symptoms and
treatment. We carried out a cross-sectional epidemiological study with analytical projection,
based on an impact study on cost per survivor. The data for the costs attributable to cases
of APC observed at HULP (outpatients and inpatients) was obtained from the based on the
information provided by the diagnosis-related groups (DRG) through the corresponding
hospital discharge reports (available through SAT-HULP).
Results
During the first 30 month of SAT-HULP operation we found a total of 3,195 APC, a cumula-
tive incidence rate of 1.75% of patients attended in the ED. The mean (SD) patient age was
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40.9 (17.8) years and 51.2% were men. Drug abuse accounted for 47.5% of the cases. Sui-
cide attempt was the second most frequent category (38.1%) and other causes accounted
for 14.5% of APC. The total cost of hospital care for our hospital rose to €1,825,263.24
(approximately €730,105.30/year) resulting in a permanent occupation of 4 beds/year.
Conclusions
SAT-HULP constitutes a validated toxicovigilance tool, which continuously integrates avail-
able data in real-time and helps health services manage APC data flexibly, including the
consumption of resources from the health system.
Introduction
Toxicovigilance is the active process of identifying and evaluating the toxic risks existing in a
community, and evaluating the measures taken to reduce or eliminate them and it is one of the
basic tasks of the services involved in caring for patients with poisonings [1–7]. This activity
requires the necessary data sources, traditionally the programs for reporting the individual (or
grouped) cases as well as retrospective and prospective epidemiological studies and surveys [5–
11]. In the setting of acute poisoning cases (APC), certain healthcare departments (emergency
departments, critical care units) are directly involved in this task [5, 6, 8, 11–13].
Added to the health costs of APC, there is a considerable financial impact on the healthcare
system due to the use of resources and the derivative costs of the various healthcare depart-
ments involved in caring for patients with poisonings [14, 15].
In December 2010, University Hospital La Paz (HULP) launched the first Clinical Toxicol-
ogy Unit (CTU) of the Community of Madrid [6]. The CTU’s initial activities included install-
ing a routine active toxicovigilance system through an automated case detection system based
on the digitized clinical reports (SAT-HULP) of patients treated in the Emergency Department
of the General Hospital (HED), in other words, adults and adolescents older than 14 years of
age. This tool has been properly evaluated and validated [6]. This active poisoning surveillance
system performs a daily search for cases in the hospital´s computerized case records.
In this study, our objectives were 1) to describe the cases of APC detected by SAT-HULP in
the first 2.5 years of operation, calculating the incidence, mortality and readmission, as well as
the factors that influence APC; 2) to calculate the impact of APC on the healthcare costs of the
Spanish National Health System (NHS) at the regional and national level.
Material and Method
Data obtained from this activity are kept in an anonymized registry and reported to the Spanish
System of Toxicovigilance as required (Sistema de Toxicovigilancia, http://www.fetoc.es/
toxicovigilancia/toxicovigilancia.html). This registry is kept within the hospital information
system and also in compliance with the Spanish Personal Data Protection Law. Verbal consul-
tation with the Ethical Committee (EC) of our Hospital (Comité Ético de Investigación Clínica
del Hospital Universitario La Paz) indicated that no previous patient informed consent or
review by the EC would be needed.
A descriptive, cross-sectional epidemiological study was conducted with analytical projec-
tion for the entire population treated in the HED during the first 2.5 years of operation of the
SAT-HULP program (April 1, 2011 to October 31, 2013).
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A descriptive statistical study was performed on the variables. The quantitative variables are
expressed as means, standard deviation and range. The qualitative variables are expressed as
absolute and relative frequencies. This descriptive statistical study was supplemented by a
trend analysis by day of the week using a time series, seasonally adjusted through its breakdown
in moving averages, thereby obtaining the corresponding seasonal factors (SF).
Factors associated with ICU admission and/or mortality and the length of
stay
We performed an initial examination of our data using a bivariate analysis, calculating the cor-
responding raw Odds Ratios of the risk factors related to the combined variable “admission to
the intensive care unit and/or mortality”. The independent variables evaluated were the age in
groups, sex, location of the initial healthcare act, the type of poisoning, the substance involved,
the categories of the Charlson index and the starting consciousness level (defined by the Glas-
gow scale score). We also included the interaction between the type of poisoning and the type
of substance in the model. We subsequently adjusted a logistic regression model using the step-
backwards method, with the variables that in the univariate analysis achieved a statistical asso-
ciation (p<0.10) or had a clear clinical and/or biological significance, using the likelihood ratio
test to include or exclude the variables that significantly contributed to the model.
Similarly, we conducted the multivariate analysis of the length of stay adjusting for a linear
regression model, where we assessed the same predictors including sex. Given that the time
variable had a non-normal behavior, we performed a logarithmic transformation of the vari-
able. We ultimately achieved a normal probability Q-Q plot to thereby have a qualitative obser-
vation of the degree of approximation to the normal of the residuals.
We considered statistical significance when the p value was<0.05.
Cost Analysis
The unit of analysis for studying the impact in costs was the patient with APC treated in the
HED, identified through the SAT-HULP program and who stayed more than 6 hours either in
the HED observation rooms or the “observation without admittance” (OWA) unit and/or who
were hospitalized. HED stays longer than 6 hours were counted as a day. The data for the costs
attributable to cases of APC observed at HULP was obtained from the repository of the Infor-
mation System of the General Subdirectorate of the Basic Portfolio of Services of the NHS and
the Cohesion Fund of the Ministry of Health, Social Services and Equality (MHSSE) based on
the information provided by the diagnosis-related groups (DRG) [16]. The DRG is a patient
classification system widely used in Spanish hospitals and in other neighboring countries. The
system helps us determine the hospital caseload (type of patients) and is of considerable useful-
ness in managing and funding hospitals. The information needed to classify each patient in
their DRG was found in the corresponding hospital discharge reports (available through
SAT-HULP) [6]. Furthermore, we were able to perform an approximation of the costs for
patients treated for APC who stayed less than 6 hours in the HED or who were do not admitted
to the OWA or to the hospital ward under the classification “emergency, not admitted”, which
is equivalent to €122 per episode, as reflected in Order 629/2009 of the Ministry of Health of
August 31, which sets the public prices for providing services and activities of a healthcare
nature of the network of centers of the Community of Madrid (CAM) [17].
For the comorbidity analysis, we chose the Charlson Index because it has the most advan-
tages and ease of handling in the most common databases. We used the most common adapted
version, thereby considering 4 separate groups (0.1–2, 3–4, and>4) [18, 19]. This index was
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accompanied by the corresponding DRG assigned during the discharge of hospitalized patients
and those admitted to the OWA.
The costs for each process were calculated according to the following formula: [equivalent
in euros of the weight of the corresponding DRG]  [number of patients classified in this
DRG] = total cost in euros. We calculated the costs per survivor for the various age groups
and the costs per survivor without readmission. The use of each CAM hospital’s resources
attributable to these patients was calculated using the analysis of the mean stay (MS) using the
various indicators (proxy) stratified by DRG. This calculation allowed us to compare the com-
plexity and operation of our center in providing care for APC with the standard of SERMAS
(Madrid Health Service) and with the other hospitals of our community’s public health system.
The data for this analysis was obtained from the 2010 minimum basic data set published by the
Ministry of Health, which served as a reference for the first year of the study period [20]. The
indicators employed in the study are shown in Table 1.
As an approximation of the clinical results, we determined for each DRG the mortality, the
HED attendance and readmissions, setting a time horizon of 30 days for visits for the same
cause or one related to the initial diagnosis and of 1 year for hospital readmissions with the
same DRG [18].
For the statistical analysis, we used the statistical suite SPSS for Windows version 17.0 and
Stata 10 (StataCorp, College Station Text).
Results
During the period from April 1, 2011 (starting date of the SAT-HULP program) to October 31,
2013 (30 months), the HED of HULP treated a total of 182,502 patients, 3195 of whom were
identified as cases of APC (1.75%) using the SAT-HULP system. Considering that HULP
serves a population of 752,006 individuals, the rate of APCs treated in the HED in HULP’s ref-
erence area is 143/100,000 inhabitants-year.
Table 2 provides a complete description of the patients’ characteristics and the poisoning
profile. The mean age of the series was 41 years (SD, 17.9), 31.7% of the patients were younger
than 31 years, and there was a slight predominance of males (51.2%). There was a significant
percentage (47.2%) of patients with previous psychiatric disease, and 36.8% had a history of
alcoholism or addiction (20.6% alcohol, 4.2% cocaine, 2% opioids and 1.8% cannabis).
Abuse and/or recreational APCs were the most common (47.5%), followed by suicidal
intent (38.1%) and accidents (14.0%). The main substances involved in the APCs were drugs of
abuse (51.7% of cases); within these, alcohol was predominant (86.5%). The second most com-
mon substances were pharmaceutical agents (41.1%), with benzodiazepines the most common
(57.3% of APCs by pharmaceutical agents), followed by oral anticoagulants (9.7%), selective
serotonin reuptake inhibitor antidepressants (5.9%), neuroleptics and new anticonvulsant
agents (both 4.3%), nonsteroidal anti-inflammatory analgesics (3.1%), paracetamol (3.7%) and
cyclic antidepressants (1.6%). In the “other substances” group (n = 133; 4.2% of the total), the
most significant APCs were related to food poisoning (38.0%). Among domestic and industrial
products (n = 96), caustic agents (20.9%) were almost on par with carbon monoxide (20.5%).
We can see from the seasonal factors (Fig 1) that Friday, Saturday and Sunday had higher
values for all cases (SF of 121.2%, 120.6% and 114.6% respectively).
The mean time from the occurrence of the APC to the initial care in the HED in those cases
that could be recorded (n = 1790; 56.0% of the total) was 4.14 hours (SD, 6.9; IQR, 2; range,
0–120), with a median time of 2 hours (Fig 2). The mean hospital stay was 1.19 days (SD, 1.24;
range, 0–30). Some 58.7% of all APC cases required a stay in the emergency department of
more than 6 hours (counted as 1 day) or hospitalization, with a mean stay of 1.99 days (SD,
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2.55; range, 1–30) and a median of 1 day. Some 10.2% (192) of all such patients were trans-
ferred to the OWA room assigned for hospital stays shorter than 48 hours.
Factors associated with ICU admission and/or mortality and the length of
the hospital stay
A total of 27 patients treated for APC required ICU admission and/or died during the admis-
sion (0.85%). Table 3 lists their characteristics. The factors independently associated with the
need for ICU admission and/or mortality in the univariate analysis are shown in Table 4.
The significantly associated risk factors include the initial care in the resuscitation box and a
Charlson Index>3. The protective factors were APCs from accidental causes and those caused
by drugs of abuse. Table 5 shows the results of the multivariate analysis. We can see that the
starting level of consciousness was a protective factor related to the severity of the APC (OR,
0.67; range: 0.59–0.76), as well as the type of poisoning (abuse or recreational) (OR, 0.21;
range: 0.08–0.56). In contrast, the initial care by prehospital emergency services is shown to be
a risk factor, with an OR of 2.80 (range, 1.22–6.45). Adjusting for the type of poisoning and the
location of initial care, we see that for every additional point in the Glasgow scale, there was an
approximately 30% lower probability of having a case of severe poisoning. Due to the colinear-
ity between the variables, we did not assess the possible interaction between the type of poison-
ing and the type of substance involved.
Similar to the previously described epigraph, we conducted the multivariate analysis of the
length of the hospital stay adjusting for a linear regression model, where the predictors of this stay
(with a p<0.05) would be age, Glasgow scale score and a history or not of psychiatric disorders.
The results can be seen in Table 6. We therefore arrived at a predicted MS value of 2.98 days.
Estimate of the financial impact of APCs
The cost of APCs for patients who remain less than 6 hours in the HED (emergency depart-
ment without hospitalization) ultimately rose to a total of €345,992 (2836 episodes).
Table 1. Indicators Employed for Evaluating the Use of Hospital Resources.
Activity Indicator Formula Description
Resource
consumption
MSAF MS/standard MS Mean stay adjusted for the function of the standard: That which they would have
had if they functioned as the standard (of SERMAS)
Measurement of
complexity
CI MSAF/SMS (standard MS) Index of complexity. Less than or greater than 1. Caseload of hospitals that are
more or less complex than the standard
DDC MSAF-SMS. Difference in complexity. Difference between the hospital’s MS and the standard
MS due to the fact that the hospital’s caseload is more or less complex
Measuring function AMSI MS of each hospital/MSAF Adjusted mean stay index. Less than or greater than 1. Operating more or less
efﬁciently than the standard. Helps analyze who can address the same caseload in
the fewest number of hospital days
Difference in
function
DDF MS of each hospital/MSAF Difference between the hospital’s MS and the standard MS due to the fact that the
hospital’s operation is more or less complex than the standard
Impact on stays IOS (Difference in MS)*
(Discharges by each hospital)
Helps determine:
• Stays saved (when negative): Stays that each hospital is saving for each DRG in
relation to the standard in SERMAS*
• Avoidable stays (when positive): Stays that each hospital could save for each
DRG in relation to the standard in SERMAS
*SERMAS: Servicio Madrileño de Salud (Madrid Health Service)
doi:10.1371/journal.pone.0152876.t001
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Through the corresponding DRGs, we also established the assessment of the treatment of
hospitalized patients, classifying them into clinically similar groups and with similar resource
consumption, such as 582, 426, 428, 449 and 750, which were the most common of the series
(Table 7). Therefore, the cost of APCs in hospitalized patients (calculated using all DRGs) ulti-
mately rose to €1,479,271.24. Table 8 includes the data on the costs by most common DRGs,
where DRGs 582, 426, 428, 449 and 750 represented 0.11%, 0.05%, 0.06%, 0.03% and 0.03%,
respectively, of the public healthcare expenditure in hospital and specialist services of the
autonomous communities. The least common DRGs (430, 751, 427 and 450) represented
0.62%, 0.05%, 0.04% and 0.02%, respectively, totaling 1.1% of this expenditure, which in turn
represents 54.77% of the total consolidated public healthcare expenditure of the national health
system (overall for the country) for the activity of 2011.
Furthermore, Table 8 contains the calculations for the cost per survivor according to DRG
by age group (the mortality is so low in almost all cases that the cost matches the unit costs)
and the cost to the system of a patient with APC surviving without requiring an acute hospital
readmission (perhaps more interesting from the funder’s point of view).
Table 2. Patients Characteristics by Type of Poisoning.
Suicide
(n = 1216)
Abuse
(n = 1517)
Accidents
(n = 447)
Homicide
(n = 15)
OVERALL*
(n = 3195)
Male sex, n (%) 414 (34.0) 1014 (66.8) 200 (44.7) 8 (53.3) 1636 (51.2)
Mean age, y (SD) 40.1 (14.7) 36.8 (15.3) 57.3 (23.3) 31.5 (12.5) 40.9 (17.8)
History of addiction, n (%) SI 475 (39.1) 652 (43.0) 43 (9.6) 4 (26.7) 1174 (36.8)
Psychiatric history, n (%) SI 955 (78.5) 488 (32.2) 64 (14.3) 1 (6.7) 1508 (47.2)
Type of substance, n (%)
Pharmaceutical agent 994 (81.7) 85 (5.6) 233 (52.1) 1 (6.7) 1313 (41.1)
Drug of Abuse 194 (16.0) 1420 (93.4) 33 (7.4) 7 (46.7) 1654 (51.7)
Domestic product 20 (1.6) - 56 (12.5) 1 (6.7) 77 (2.4)
Industrial product 4 (0.3) 1 (0.1) 13 (2.9) - 18 (0.6)
Other (including food poisoning) 4 (0.3) 11 (0.7) 112 (25.1) 6 (40.0) 133 (4.2)
Symptoms at admission, n (%) SI 828 (68.1) 1461 (96.3) 312 (69.8) 14 (93.3) 2615 (81.8)
Laboratory measurements, n (%) SI 429 (35.3) 277 (18.3) 223 (49.9) 12 (80.0) 941 (29.5)
Digestive decontamination, n (%) SI 504 (41.4) 25 (1.6) 12 (2.7) 2 (13.3) 543 (17.0)
Use of antidote, n (%) SI 266 (21.9) 53 (3.5) 106 (23.7) 2 (13.3) 427 (13.4)
Patient destination, n (%)
Emergency Department Discharge 957 (78.7) 1427 (94.1) 419 (93.7) 12 (80.0) 2815 (88.1)
ICU Admission 26 (2.1) 4 (0.3) - - 30 (1.0)
Ward Admission 30 (2.5) 9 (0.5) 11 (2.5) - 50 (1.5)
Exitus 1 (0.1) - 3 (0.7) - 4 (0.1)
Transfer 115 (9.5) 19 (1.3) 6 (1.3) 1 (6.7) 141 (4.4)
Voluntary discharge 12 (1.0) 45 (3.0) 5 (1.1) 2 (13.3) 64 (2.0)
Admission to Psychiatry Unit 75 (6.2) 13 (0.9) 3 (0.7) - 91 (2.8)
Comorbidities, n (%) (according to Charlson Index for
hospitalized patients)
Charlson Index 0 160 (14.4) 20 (3.4) 10 (6.1) 1 (14.3) 191 (10.2)
Charlson Index 1–2 109 (9.8) 26 (4.4) 10 (6.1) - 145 (7.7)
Charlson Index 3–4 11 (0.5) 3 (0.5) 6 (3.7) - 20 (1.1)
Charlson Index >4 5 (0.5) 1 (0.2) 1 (0.6) - 7 (0.4)
*The between groups observed differences are statistically signiﬁcant (p <0.05) in all cases.
doi:10.1371/journal.pone.0152876.t002
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Therefore, the total cost of hospital care for patients with APC detected during the 30
months of the program’s operation rose to €1,825,263.24 (which represents approximately
€730,105.30/year).
Once the overall indicators for the hospital’s caseload and operation were calculated, we
proceeded to individually compare the differences between the mean stay at our center and the
standard mean stay of SERMAS (Department Health Service) for each DRG. This procedure
helped us compare the operation of HULP (adjusting by caseload) with that of the other cen-
ters with similar characteristics in the Community of Madrid, as well as the evolution of our
center’s operation by quarter. The results are shown in Figs 3 and 4. Fig 5 shows the evolution
of resource consumption for the study period (this is necessary for the Benchmarking of CTU).
Fig 6 shows our hospital’s situation compared with that of the other reference centers of the
region in terms of the complexity of the caseload (Complexity Index, 0.87), coming in sixth in
complexity after the the rest of high complexity hospitals SERMAS (La Princesa, La Paz, Doce
Fig 1. The trend by day of the week. It can be seen as cases of poisoning abusive rises on Friday and Saturday, the suicide type throughout the weekend
and accidentally nature clearly in Sunday (likely by the weight of domestic accidents).
doi:10.1371/journal.pone.0152876.g001
Fig 2. Healthcare Interval. The distribution of time from reported ingestion to presentation by plotting the number of patients presenting in each hour block.
doi:10.1371/journal.pone.0152876.g002
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de Octubre, Ramon y Cajal, Clínico San Carlos, Gregorio Maranon and Puerta de Hierro) for
GRDs referrals. Has to be taken in mind that our hospital does not perform transplants adult
(except kidney) and sociodemographic characteristics of the reference population. Can be con-
sulted calculations and data source used in S1–S3 Files.
Some 93.59% of the patients who were hospitalized or admitted to the OWA had a single
episode during the follow-up period. HED attendance for APC according to the Charlson
Index category (presence of comorbidities) was as follows: 5.8% for a Charlson Index of 0, 8.3%
for a Charlson Index of 1 to 2 and 5.0% for a Charlson Index of 3 to 4. There are no cases of
attendance for Charlson Indices>4. The cost overrun for the NHS represented by these cases
is included in the calculations shown above.
Table 3. Characteristics of Patients Requiring Admission to the Intensive Care Unit (ICU) and/or who
Died.
ICU admission N
(%)
Exitus N
(%)
Male sex 12 (40.0) 3 (75.0)
Age group
15 years of age or younger - -
16–30 years 10 (33.3) -
31–45 years 11 (36.7) 2 (50.0)
46–60 years 7 (23.3) -
61–75 years 2 (6.7) -
76 years of age or older - 2 (50.0)
Psychiatric history [YES] 21 (70.0) 1 (25.0)
Type of poisoning
Suicide 26 (86.7) 1 (25.0)
Abusive/Recreational 4 (13.3) -
Accidents - 3 (75.0)
Homicide - -
Type of substance
Pharmaceutical agent 26 (86.7) 3 (75.0)
Drug of Abuse 4 (13.3) 1 (25.0)
Domestic product - -
Industrial product - -
Other -
Initial care
Emergency Room/Consultation 8 (26.7) 1 (25.0)
Resuscitation Box 7 (23.3) 1 (25.0)
Outpatient 15 (50.0) 2 (50.0)
Comorbidity (according to Charlson Index for hospitalized
patients)*
Charlson Index 0 20 (66.7) -
Charlson Index 1–2 9 (30.0) 1 (25.0)
Charlson Index 3–4 1 (3.3) 1 (25.0)
Charlson Index >4 - 1 (50.0)
*The Charlson Index was calculated in only 3 of the 4 death as this calculation can only be made in
hospitalized patients. The 4th patient died in the emergency department.
doi:10.1371/journal.pone.0152876.t003
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Discussion
Toxicovigilance, as an essential part of the portfolio of services of a Clinical Toxicology Unit,
consists of a healthcare information system that continuously and systematically collects data
on the effects of xenobiotics in human health and its impact on healthcare systems [5, 6].
This activity is encompassed within the syndromic surveillance systems of morbidity and
mortality. The main objective of these systems is the early detection of events that can signifi-
cantly affect public health. The systems must undergo frequent updates and provide rapid
access to information. The system facilitates the implementation of strategies for the early and
quick resolution of detected problems, thus reducing the magnitude of the damage for the pop-
ulation and the burden on the healthcare system [6–8]. An important attribute of the
SAT-HULP program is its ability to provide disaggregated data for other variables of interest
such as age, sex and comorbidity, thereby providing additional advantages for redistributing
healthcare resources among population groups within a scenario of heavy healthcare demand
[21]. In addition, this cases capture system represents a significant strength compared to simi-
lar studies based on reviews of clinical and administrative databases (coded definitive diagno-
ses) because these can lose a significant proportion of APC [22, 23].
It is important to note that our program robustly detects that the proportion of men in APC
is slightly higher, which corresponds with the studies performed in Spain, and is in contrast to
the results of series in other countries, where the female/male proportion can reach a ratio of 3/
1 [4, 6, 9, 13, 24–27].
With regard to poisonings from substances of abuse, we can link our series to a pattern of
festive consumption, preferentially associated with weekends (similar to the results of
Table 4. Factors Associated with Admission to the Intensive Care Unit and/or in-hospital mortality
(univariate analysis).
OR (95% CI) p-Value
Male sex 0.7 (0.4–1.5) 0.396
Psychiatric history [YES] 1.6 (0.4–6.6) 0.551
Type of poisoning
Suicide 1.0 -
Abusive/Recreational 0.2 (0.1–0.4) 0.000
Accidents 0.1 (0.0–7.6) 0.006
Homicide 0.0 0.567
Type of substance
Pharmaceutical agent 1.0 -
Drug of Abuse 0.1 (0.0–0.3) 0.000
Domestic product 0.0 0.195
Industrial product 0.0 0.531
Other 0.0 0.089
Initial care
Emergency Room/Consultation 1.0 -
Resuscitation Box 50.8 (16.6–155.5) 0.000
Outpatient 4.3 (1.9–9.6) 0.000
Comorbidity (according to Charlson Index for hospitalized patients)
Charlson Index 0 1.0 -
Charlson Index 1–2 1.1 (0.6–2.1) 0.713
Charlson Index 3–4 8.1 (2.9–22.8) 0.000
Charlson Index >4 8.8 (1.8–43.9) 0.001
doi:10.1371/journal.pone.0152876.t004
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published studies) [24, 27–29]. The frequencies of the type of drug used (alcohol 83.1%,
cocaine 6.6%, cannabis 2.7%, amphetamines 0.8% and opioids 0.5%) differs slightly from the
majority of sources consulted, in which cannabis is ahead of cocaine [14, 29]. Furthermore,
15.7% of the abuse APCs was caused by a combination of alcohol and drugs or by multiple
drug use. Some 8.7% of the cases were associated with psychoactive drugs, for the most part
benzodiazepines (6.9%), which confirms the increasing progress of mixed poisonings caused
by the combination of alcohol, various drugs and psychoactive pharmaceuticals [13, 24, 26, 27,
29, 30].
As with most of the published studies, we can see that acute poisonings from drugs of abuse
mainly occur in young individuals, towards whom efforts to prevent this public health problem
should be directed. We can see a high percentage (43%) of patients with a history of alcoholism
or addiction, and 32.2% have prior psychiatric disease. Unlike other published series, the
Table 5. Multivariate Analysis Risk factors for severe poisoning (ICU admission and/or exitus). LR Χ2 = 88.97, Prob> Χ2 = 0.0000 and PseudoR2 =
0.2519.
Standard Error Signiﬁcance (p) OR 95% CI
Initial Care Resuscitation Box 2.795 0.092 3.646 0.811–16.385
Initial care Outpatient 1.192 0.015 2.801 1.217–6.448
Type of poisoning Abuse/Recreational 0.105 0.002 0.207 0.077–0.558
Initial level of consciousness (GCS score) 0.043 0.000 0.668 0.588–0.758
doi:10.1371/journal.pone.0152876.t005
Table 6. Multivariate Analysis Predictors of mean hospital stay. F = 9.655, p = 0.000, R2 = 0.076, R2
adjusted = 0.068.
Standardized
coefﬁcients
t Signiﬁcance 95% CI for B
(nonstandardized)
Beta LI LS
Constant - 5.766 0.000 0.602 0.882
Initial level of consciousness (GCS
score)
-0.185 -3.612 0.000 -0.044 -0.206
Age 0.166 3.249 0.001 0.001 0.002
Psychiatric history [SI] -0.119 -2.338 0.020 -0.078 -0.034
doi:10.1371/journal.pone.0152876.t006
Table 7. Frequencies of the Various DRGs in Patients Hospitalized for Acute Poisoning in HULP (OWOH and hospitalization).
DRG DESCRIPTION Weight Unit Cost Frequency,%
428 Personality disorders and impulse control 0.7208 €3,546.04 37.0
582 Injuries, poisonings and toxic effects of drugs, except for multiple trauma with major complications 1.4270 €7,020.34 11.7
426 Depressive neurosis 0.9358 €4,603.97 11.4
750 Alcohol abuse or dependence with complications 0.9408 €4,628.55 8.6
449 Poisoning and toxic effect of drugs. Older than 17 years with complications 0.6690 €3,291.39 6.4
430 Psychosis 1.3410 €6,597.63 4.7
427 Neurosis, except for depression 0.8194 €4,031.21 4.5
751 Alcohol abuse or dependence without complications 0.8128 €3,999.03 3.9
450 Poisoning and toxic effect of drugs. Older than 17 years without complications 0.4656 €2,290.47 3.3
Other Miscellaneous (84,102,127,395,425,429,432,455,544,744,745) See Reference 43: 8.5
doi:10.1371/journal.pone.0152876.t007
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consumption of multiple drugs was not a risk factor in our study for the increase in ICU admis-
sions [1, 6, 30]. It is worth noting that after the overwhelming media and political impact
resulting from the use of ecstasy and amphetamines in the mid-1990s, their usage trends seem
to be stable. The use of cannabis, however, has grown considerably, with an annual usage rate
of 11.25% among the 15–64 age group and 19.85% for the 15–34 age group. It is estimated that
there are more than half a million daily consumers of cannabis in Europe [29, 30]. Thus, the
HULP CTU toxicovigilance system can help determine the characteristics and trends of prob-
lematic drug use and can act as an early warning system for detecting changes in the phenome-
non (new drugs or usage forms) [6, 7].
Fig 3. Impact on stays (IOS) among the Main University Hospitals of the Community of Madrid with 1100 Beds or More Beds. This figure represent
the number of stays saved (negative figures) or the avoidable stays (positive figures) for each hospital in relation to the standard mean stay in the SERMAS
for the most relevant DRG (see Table 6 for description). For details on calculation see also Table 1. H.U.L.P: University Hospital La Paz. H. 12 D. O: Hospital
12 de Octubre. H.C.S.C: Hospital Clínico San Carlos. H.R.Y.C: Hospital Ramón y Cajal. H.G.U.G.M: General University Hospital Gregorio Marañón.
doi:10.1371/journal.pone.0152876.g003
Fig 4. Evolution of IOS in HULP by semester and for eachmain DRG. The evolution of this indicator is necessary for the appropriate Benchmark.
doi:10.1371/journal.pone.0152876.g004
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Our results for the analysis of risk factors related to poisoning severity (ICU admission and/
or exitus) are fairly similar to those recorded in the literature. The initial consciousness level,
the emergency department’s point of care, the type of APC (abuse or recreational) and care by
prehospital emergency services all were shown to be robust predictors (after adjusting for age
and sex). There was no interaction between age and sex or the degrees of comorbidity (Charl-
son Index categories) [30–32]. An important part of our study focused on the analysis of
resource consumption and costs for hospitalized patients, where the impact of age on the
length of stay deserves a special mention. There are a number of studies that have examined
the impact of age on mortality and the length of the hospital stay, but their results have not
been conclusive [19,]. In our study, age was a significant predictor of the length of the hospital
stay, although its weight in the construction of the model was low. One of the possible explana-
tions for the relatively modest role of age is that young patients who require hospitalization
tend to have proportionally more severe acute disease processes and lower physiological scores.
As a result, they have comparatively similar mortality rates and hospital stays to those of older
patients [19, 31, 33], which would mean that the equation resulting from our hospital stay
model should only be used as guidance. If we compare the costs at our center with those of
other similar tertiary hospitals within the Madrid Health Service (adjusting for age, initial con-
sciousness level and the presence or absence of psychiatric antecedents), the results of the
model help us detect whether there are significantly larger differences in the mean stay, thereby
establishing an exploratory overview of the practices and caseload in this center.
Care for APC is a process that consumes a significant amount of resources in terms of spe-
cialized personnel in emergency departments and ICUs and requires the participation of other
departments (e.g., psychiatry, pharmacy and toxicology), thereby highlighting the importance
of Multidisciplinary Functional Units for toxicology care. Despite the efforts of scientific socie-
ties and consensus groups, few methods have been developed to manage and assess the appro-
priate use of resources and the length of stays for APC [14, 15, 22, 23, 34]. In this context,
SAT-HULP represents a toxicovigilance tool that also helps integrate the data sources needed
Fig 5. Evolution of quarterly resource consumption (see Table 1). It is seen as long as the complexity of
the hospital (CI) is practically constant, the mean stay of our hospital (MS) remains at significantly lower
values compared to the standard of all hospitals in the Community of Madrid (MSAF) for all DRGs involved.
doi:10.1371/journal.pone.0152876.g005
Outcomes and Costs of Poisoned Patients: Evaluation of a Toxicovigilance Program
PLOSONE | DOI:10.1371/journal.pone.0152876 April 21, 2016 13 / 18
to continuously calculate the costs and resource consumption associated with providing care
for APC thus complementing traditional systems [14, 22, 23, 35].
Our study reveals significant variability among centers in terms of resource consumption
for the various DRGs involved. Despite current debate about this information source [36, 37],
the DRG system has the advantage of grouping patients with similar processes, which is com-
parable among various units and centers. The analysis of the variability in the use of resources
helps us understand whether the use of healthcare teams with greater experience in providing
care for APC helps achieve better results, which is consistent with other studies that have linked
the caseload of hospitals for complicated processes and critically ill patients to better results
[36–38]. It is of epidemiological interest and useful for healthcare planning to observe how the
evolution of this resource consumption by DRG is subject to seasonal variations, unlike the
complexity of the treated patients (which remains steady), a phenomenon already observed in
various publications [14, 15, 17, 22, 23, 39].
With regard to the influence of comorbidity (as assessed through the Charlson Index), the
underlying hypothesis is that adverse health results increase as comorbidity increases. How-
ever, a number of studies that have analyzed long-term readmissions have stated that the
Fig 6. Complexity Index (CI, see Table 1) of the various healthcare areas of the SERMAS. >1, the caseload of the reference hospital is more complex
than the regional standard. <1, the caseload of the reference hospital is less complex than the regional standard. The values represented correspond to the
higher complexity hospitals. The index for HULP as a reference center appears surrounded by an oval. Reprinted from figure 6 under a CC BY license, with
permission from Raul Muñoz, original copyright 2015.
doi:10.1371/journal.pone.0152876.g006
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influence of comorbidity is determined by the relationship between 2 competitive risks: mortal-
ity and readmission. Due to the nature of the Charlson Index, which excludes acute diseases,
the index can behave as a protective factor against mortality (as observed in readmission data
by Charlson Index), although it is not really in the purely epidemiological sense. This paradoxi-
cal effect can be even more apparent in the short-term results of severe processes, due to the
fact that hospital mortality can be greater among patients with no or with minimal comorbidity
than in other patients (contrary to a priori expectations). This could therefore explain the
absence of statistical significance for the various Charlson Index categories, as well as its possi-
ble interaction with age as a predictor of mortality [33, 36, 40, 41].
After analyzing readmissions by DRG and in accordance with the data reported by various
authors [14, 22, 23, 39, 41–44] we observed that patients who were readmitted had a lower
severity of APC and medical comorbidity, with a more favorable clinical outcome but with
greater psychiatric comorbidity and an increased risk of attempted suicide. These patients are
therefore candidates for assessment and subsequent treatment by the psychiatry unit, both in
the acute phase and the medium to long-term, as they would correspond at DRGs 750, 428 and
426. By observing the costs per survivor without readmission, we see that these patients require
a significant amount of resources from the system (Table 6b). As a result, the Department of
Psychiatry plays a special role in the process of comprehensive care for APCs, thereby
highlighting one the strengths of our center’s organizational care: All cases of APC that present
as autolytic attempts are evaluated psychiatrically. This policy supports the need for the multi-
disciplinary nature of the CTU as it has been shown in recent studies [22, 34].
Conclusions
Finally, our study shows that the costs of APC represent a considerable sum within the total
consolidated public health expenditure of the NHS (€32,715,760,000) for the activity corre-
sponding to 2011. The cost per hospitalized patient (€4,120.53) is greater than a number of
published results ($1,776 on average) and lower than those attribute to the harmful use of opi-
oid analgesics ($15,884 to $18,388) but very similar to the results for the most complete and
recent studies for patients who consume more resources ($4,821.49 in upper quintile). The lat-
ter figures are close to our results for survivors without readmission aged 15 to 45 years, who
represent 50% of these costs [14,15,22,23,39]. Although these figures should be assessed with
caution due to the differences among the various national health systems, we should consider
the similarity of the institutions and the healthcare departments involved, which belong to the
public healthcare networks in almost all cases. Furthermore, from the perspective of the impact
on costs at the regional level and of the opportunity cost of using hospital beds and taking into
account that the annual expenditure by bed in specialized care in the Community of Madrid
for the same exercise [20, 44] rises to approximately €187,193, we would have about 4 beds in
our center (752,006 population attended by our hospital) occupied on a permanent basis by
these patients for a year (the ratio of beds/1000 inhabitants in the Community of Madrid is
2.87) [20]. Finally, we can see that for DRGs 582, 426, 428, 449 and 750, the proportion of
cases due to APC (out of the total) at 1 year in our hospital is 21.55%, 55.1%, 53%, 34.6% and
41%, respectively. If we roughly extrapolate to the rest of Spain [16, 44], this would represent
total costs of €8,029,618.93, €10,695,298.52, €11,111,536.42, €34,139.90 and €3,653,636.81. The
figures mentioned above represent a significant impact on costs for the NHS. Therefore, the
majority of efforts in preventive strategies and the planning of health services should be
directed towards this type of young patient, taking into account their special social relevance
[14, 15, 22, 23, 27, 29, 31, 39].
Outcomes and Costs of Poisoned Patients: Evaluation of a Toxicovigilance Program
PLOSONE | DOI:10.1371/journal.pone.0152876 April 21, 2016 15 / 18
In conclusion, SAT-HULP constitutes a validated toxicovigilance tool, which continuously
integrates available data sources in real-time and helps health services manage APC data flexi-
bly. The results from 30 months of operation show APC characteristics similar to those
described in the literature. SAT-HULP thereby helps assess the evolution of the severity of
APC in our community, including the consumption of resources from the health system,
which rises to a mean cost per patient (all inclusive) of €571.29.
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